DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
ROCKET AF Study Investigators.
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
Am Heart J 2010;
159 (03) 340-347
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.